Covid-19: what has changed and is likely to change further, in the relationships among EMA, National Regulatory Authorities and Healthcare Industries Worldwide. REGISTER FOR THE WEBINAR
On March 25 at 5 pm CET we invite you to attend the Webinar dedicated to International Pharma & Healthcare Administration, the new Executive Programme of Luiss Business School delivered online and in the Amsterdam Hub and that equips participants with the know-how necessary to manage most relevant ethical, economical and organizational challenges of the evolution of healthcare.
The topic of the Webinar
Covid-19: what has changed and is likely to change further in the relationships among EMA, National Regulatory Authorities and Healthcare Industries Worldwide.
The specific themes that Prof. Rasi will cover during the webinar concern the need to rebalance national vs central activities and the convergence of technology vs convergence of regulations.
The Speakers
Guido Rasi, Professor of Microbiology, Università Tor Vergata; Former EMA (European Medicines Agency) Executive Director; Former AIFA (Agenzia del Farmaco Italiana) General Director
Luca Magni, Professor of Practice, Luiss Business School and Scientific Director, Executive Programme in International Pharma and Healthcare Administration
Agenda
5.00 – 5.15 pm: Opening and Brief Introduction to the upcoming Executive Programme in International Pharma & Healthcare Administration (Prof Luca Magni)
5.15 – 5.45 pm: Covid-19: what has changed and is likely to change further, in the relationships among EMA, National Regulatory Authorities and Healthcare Industries Worldwide. (Prof. Guido Rasi)
5.45 – 6.00 pm: Q&A
Participants and speakers can interact during the Q&A session. In particular, for those interested in the Executive Programme in International Pharma & Healthcare Administration, the programme coordinator will be happy to answer all questions through the dedicated chat.
The event is free upon registration
